HK1147700A1 - Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man - Google Patents

Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man

Info

Publication number
HK1147700A1
HK1147700A1 HK11101957.6A HK11101957A HK1147700A1 HK 1147700 A1 HK1147700 A1 HK 1147700A1 HK 11101957 A HK11101957 A HK 11101957A HK 1147700 A1 HK1147700 A1 HK 1147700A1
Authority
HK
Hong Kong
Prior art keywords
diabetes
treatment
type
pharmaceutical composition
mammals including
Prior art date
Application number
HK11101957.6A
Other languages
English (en)
Inventor
Kaihong Yuan
Shuqin Ma
Yafei Zhu
Leiming Li
Original Assignee
Jiangsu Hengrui Medicine Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co filed Critical Jiangsu Hengrui Medicine Co
Publication of HK1147700A1 publication Critical patent/HK1147700A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11101957.6A 2009-06-08 2011-02-28 Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man HK1147700A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009101406134A CN101904840B (zh) 2009-06-08 2009-06-08 治疗哺乳动物包括人2型糖尿病的药物组合物

Publications (1)

Publication Number Publication Date
HK1147700A1 true HK1147700A1 (en) 2011-08-19

Family

ID=43260529

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11101957.6A HK1147700A1 (en) 2009-06-08 2011-02-28 Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man

Country Status (3)

Country Link
CN (1) CN101904840B (xx)
HK (1) HK1147700A1 (xx)
WO (1) WO2010142183A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104030967B (zh) * 2013-03-05 2018-01-02 连云港恒运药业有限公司 一种dpp‑iv抑制剂的中间体、其制备方法和通过其制备dpp‑iv抑制剂的方法
WO2021057661A1 (zh) * 2019-09-27 2021-04-01 深圳信立泰药业股份有限公司 一种降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045039A (zh) * 2001-09-28 2007-10-03 太阳医药工业有限公司 糖尿病治疗剂型
JP5165582B2 (ja) * 2005-12-16 2013-03-21 メルク・シャープ・エンド・ドーム・コーポレイション ジペプチジルペプチダーゼ−４インヒビターとメトホルミンとを組み合わせた医薬組成物
CN101230059B (zh) * 2007-01-23 2011-08-17 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途

Also Published As

Publication number Publication date
CN101904840B (zh) 2012-02-08
CN101904840A (zh) 2010-12-08
WO2010142183A1 (zh) 2010-12-16

Similar Documents

Publication Publication Date Title
ZA200902374B (en) Compositions useful for the treatment of diabetes
HK1163500A1 (en) Pharmaceutical composition for the treatment of heart diseases
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
HK1170490A1 (zh) 用於青光眼的治療或預防的醫藥組合物
EP2236149A4 (en) MEDICAL COMPOSITION
HK1141447A1 (en) Pharmaceutical composition for the treatment of proliferative diseases
PT2358373E (pt) Composição injetável de polidesoxirribonucleotídeos para o tratamento de doenças osteoarticulares
IL223289A (en) The history of triazine and pharmaceutical preparations containing them for the treatment of type 2 diabetes
PT2429507T (pt) Composição farmacêutica isenta de fosfatos para o tratamento do glaucoma
IL208463A (en) 2-Trotocyclic-Pirol compounds combined, pharmaceutical preparations containing them and their use in the prevention or treatment of diabetes or obesity
ZA201009072B (en) Pharmaceutical composition for the treatment of premature ejaculation
PT2842555T (pt) Derivados-alfa de ácidos gordos cis-monoinsaturados para uso como medicamentos no tratamento de diabetes
HK1156844A1 (en) Pharmaceutical composition 271 271
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
PL2298090T3 (pl) Kompozycja farmaceutyczna lub nutraceutyczna
IL200753A (en) Pharmaceutical preparation containing ib – meca for the treatment of psoriasis
HK1147700A1 (en) Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man
EP2402342A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING TYPE 2 DIABETES
ZA201204341B (en) Pharmaceutical composition for treating gutaneous burns
HK1145445A1 (en) Pharmaceutical composition for losing weight or for treating metabolic syndromes
HK1145447A1 (en) Pharmaceutical composition for losing weight or for treating metabolic syndromes
PT2344166E (pt) Composição farmacêutica para o tratamento da irritação gastrointestinal
PL2307380T3 (pl) Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego
EP2331099A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES MELLITUS

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220606